Clinical trial
Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil…
NCT00307242 · Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00307242 |
|---|---|
| Title | Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B |
| Official title | A Single Center Open-Label, Randomized Study Comparing the Safety of Immediately Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir for 12 Weeks Before Instituting Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B |
| Lead sponsor | Thomas Jefferson University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Adefovir Dipivoxil |
| Enrollment | 40 |
| Start date | Jun 17, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 5, 2009 |
| First posted | Mar 27, 2006 |
| Last update posted | Nov 12, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: